Nippon India Pharma Fund - Direct (G) vs UTI-Nifty 50 Index Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs UTI-Nifty 50 Index Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

UTI-Nifty 50 Index Fund - Direct (G)

-2.46%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Stock Holding Corporation of India Limited Citibank NA HDFC Bank Limited

Computer Age Management Services Pvt Ltd.(CAMS) Datamatics Financial Software & services Limited Karvy Computershare Pvt. Ltd. UTI Technology Services Ltd.

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Very High Risk

1000

28685.14

0.12

168.7122

January 1, 2013

0

14.01 %

19.35 %

7.4 %

9.83 %

7.92 %

-2.46 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Kaushik Basu

B.Com, ACMA B.Com(Hons), CAIIB (I), ICWA, LLB.

He has an overall experience of 26 years including 12 years in the domestic Equity Capital markets. He in his earlier days has worked in the areas of Accounts and Money Market of erstwhile Unit Trust of India. He has worked as Equity Dealer for UTI and UTI AMC for 4 years.

Sharwan Kumar Goyal

B.Com, MMS, CFA,

He began his career with UTI in June 2006 and has over 11 years of experience in Risk Management, Equity Research and Portfolio Analysis. Presently he is working as Fund Manager for Overseas Investments.

Get your FAQs right